Literature DB >> 33880767

Visualising and understanding cGMP signals in the cardiovascular system.

Robert Feil1, Moritz Lehners1, Daniel Stehle1, Susanne Feil1.   

Abstract

cGMP is an important signalling molecule in humans. Fluorescent cGMP biosensors have emerged as powerful tools for the sensitive analysis of cGMP pathways at the single-cell level. Here, we briefly outline cGMP's multifaceted role in (patho)physiology and pharmacotherapy. Then we summarise what new insights cGMP imaging has provided into endogenous cGMP signalling and drug action, with a focus on the cardiovascular system. Indeed, the use of cGMP biosensors has led to several conceptual advances, such as the discovery of local, intercellular and mechanosensitive cGMP signals. Importantly, single-cell imaging can provide valuable information about the heterogeneity of cGMP signals within and between individual cells of an isolated cell population or tissue. We also discuss current challenges and future directions of cGMP imaging, such as the direct visualisation of cGMP microdomains, simultaneous monitoring of cGMP and other signalling molecules and, ultimately, cGMP imaging in tissues and animals under close-to-native conditions. LINKED ARTICLES: This article is part of a themed issue on cGMP Signalling in Cell Growth and Survival. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.11/issuetoc.
© 2021 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.

Entities:  

Keywords:  FRET microscopy; VSMC; biosensor; cardiomyocyte; cell heterogeneity; compartmentation; guanylyl cyclase; imaging; microdomain; natriuretic peptide; nitric oxide; phosphodiesterase; platelet; signalling; transgenic mice

Mesh:

Substances:

Year:  2021        PMID: 33880767     DOI: 10.1111/bph.15500

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

Review 1.  Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure.

Authors:  Rima Kamel; Jérôme Leroy; Grégoire Vandecasteele; Rodolphe Fischmeister
Journal:  Nat Rev Cardiol       Date:  2022-09-01       Impact factor: 49.421

2.  Endothelial Nitric Oxide Synthase (eNOS) and the Cardiovascular System: in Physiology and in Disease States.

Authors:  N Tran; T Garcia; M Aniqa; S Ali; A Ally; S M Nauli
Journal:  Am J Biomed Sci Res       Date:  2022-01-04

Review 3.  Flow cytometry based-FRET: basics, novel developments and future perspectives.

Authors:  JiaWen Lim; Moritz Petersen; Maximilian Bunz; Claudia Simon; Michael Schindler
Journal:  Cell Mol Life Sci       Date:  2022-03-30       Impact factor: 9.207

4.  Optogenetic manipulation of cyclic guanosine monophosphate to probe phosphodiesterase activities in megakaryocytes.

Authors:  Yujing Zhang; Pascal Benz; Daniel Stehle; Shang Yang; Hendrikje Kurz; Susanne Feil; Georg Nagel; Robert Feil; Shiqiang Gao; Markus Bender
Journal:  Open Biol       Date:  2022-08-17       Impact factor: 7.124

Review 5.  Amelioration of endothelial dysfunction by sodium glucose co-transporter 2 inhibitors: pieces of the puzzle explaining their cardiovascular protection.

Authors:  Xiaoling Li; Benedikt Preckel; Jeroen Hermanides; Markus W Hollmann; Coert J Zuurbier; Nina C Weber
Journal:  Br J Pharmacol       Date:  2022-04-22       Impact factor: 9.473

Review 6.  PDE-Mediated Cyclic Nucleotide Compartmentation in Vascular Smooth Muscle Cells: From Basic to a Clinical Perspective.

Authors:  Margarida Lorigo; Nelson Oliveira; Elisa Cairrao
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.